Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07416617

Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction

The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acute Myocardial Infarction Dyssomnias Insomina Mental Disorders Nervous System Diseases Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of acute myocardial infarction
  • Undergoing percutaneous coronary intervention or coronary artery bypass surgery

Exclusion criteria

  • Pre-existing phychiatric disorders

Treatment and study plan

Insomnia medication

Drug

Diagnosed as insomnia and use of anti-insomnia medication

No insomnia medication

Other

Diagnosed as insomnia and did not use of anti-insomnia medication

Primary outcomes

  1. Rates of MACCE

    Time frame: up to 10 years

    a composite of death, spontaneous MI, repeat revascularization, and ischemic stroke

Secondary outcomes

  1. Rates of Death

    Time frame: up to 10 years

    All-cause death

  2. Rates of Revascularization

    Time frame: up to 10 years

    repeat revascularization

  3. Rates of Spontaneous MI

    Time frame: up to 10 years

    MI

  4. Rates of Ischemic stroke

    Time frame: up to 10 years

    Stroke

Study contacts

Contact information is provided by the study sponsor or research team.

Ki Hong Choi, MD, PhD

CONTACT

[email protected]

+82234100897

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Acronym: MI-INSOMINA

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 18, 2026
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.